Skip to main content

Table 6 Comparison of patients with drug-resistant epilepsy and with 1-year remission at the end of the study by etiology of symptomatic epilepsy

From: The long-term prognosis and predictors of epilepsy: a retrospective study in 820 patients

  DRE (%) n = 160 Remission (%) n = 100 OR (95% CI) P-value
Cerebral trauma 38 (23.8) 28 (28.0) 0.80 (0.45–1.41) 0.444
Mesial temporal sclerosis 38 (23.8) 18 (18.0) 1.42 (0.76– 2.66) 0.273
Meningitis/encephalitis 33 (20.6) 8 (8.0) 2.99 (1.32–6.77) 0.007
Unclear encephalomalacia 11 (6.9) 11 (11.0) 0.60 (0.25–1.43) 0.245
Cortical malformation 11 (6.9) 6 (6.0) 1.16 (0.41–3.23) 0.781
Perinatal brain injury 5 (3.1) 8 (8.0) 0.37 (0.12–1.17) 0.079
Cerebral vascular malformations 4 (2.5) 2 (2.0) 1.67 (0.30–9.23) 0.693
Neurocutaneous syndromes 2 (1.3) 0 (0) NC 0.262
Cerebral tumor 1 (0.6) 1 (1.0) 0.62 (0.04–10.07) 1.000
Stroke 0 2 (2.0) NC 0.14
Unknown 17 (10.6) 16 (16.0) 0.70 (0.34–1.45) 0.334
  1. DRE drug resistant epilepsy, NC not calculated because one of the cells has a zero value, 95% CI 95% confidence intervals